Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

The mutational impact of culturing human pluripotent and adult stem cells

Open access
Kuijk, Ewart, Jager, Myrthe, van der Roest, Bastiaan, Locati, Mauro D., Van Hoeck, Arne, Korzelius, Jerome, Janssen, Roel, Besselink, Nicolle, Boymans, Sander, van Boxtel, Ruben, Cuppen, Edwin · 2020 · Nature Communications

Published version of a preprint

Abstract

Genetic changes acquired during in vitro culture pose a risk for the successful application of stem cells in regenerative medicine. To assess the genetic risks induced by culturing, we determined all mutations in individual human stem cells by whole genome sequencing. Individual pluripotent, intestinal, and liver stem cells accumulate 3.5 ± 0.5, 7.2 ± 1.1 and 8.3 ± 3.6 base substitutions per population doubling, respectively. The annual in vitro mutation accumulation rate of adult stem cells is nearly 40-fold higher than the in vivo mutation accumulation rate. Mutational signature analysis reveals that in vitro induced mutations are caused by oxidative stress. Reducing oxygen tension in culture lowers the mutational load. We use the mutation rates, spectra, and genomic distribution to model the accumulation of oncogenic mutations during typical in vitro expansion, manipulation or screening experiments using human stem cells. Our study provides empirically defined parameters to assess the mutational risk of stem cell based therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-16323-4

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 In vitro mutation accumulation in PSCs (n = 5), liver stem cells (n = 4), and intestinal stem cells (n = 6). a Schematic overview of the experimental setup to determine in vitro-accumulated mutations in individual human PSCs, liver stem cells, and intestinal stem cells. Clonal stem cell lines were cultured for ~2–5 months during which mutations were allowed to accumulate. At the end of the culture period, a second clonal step was performed, and the derivative subclones were expanded until enough DNA could be isolated for WGS analysis. A biopsy or bulk culture was used as a reference sample to determine and exclude all germline variants, which were subtracted from the clone (comparison 1) and from the subclone (comparison 2). Finally, with these results, the clonal variants were subtracted to identify all variants that were unique to the subclone. b Growth curves for PSCs (green), liver stem cells (red), and intestinal stem cells (blue). c Box–whisker plots showing the median, first and third quartiles, and minimum and maximum of the number of indels per genome per population doubling (statistical test used: ANOVA). d Box–whisker plots showing the median, first and third quartiles, and minimum and maximum of the number of SBS per genome per population doubling. Statistical test used: ANOVA. e Top panels: genomic distribution of the observed versus the expected amount of mutations per genome per doubling. Bottom panels: log2 of the ratio between the total number of observed mutations versus the total number of the expected amount of mutations. Asterisks denote statistically significant differences between observed and expected (binomial test). CDS coding sequence. f Relative number of SBS per cell type (left circles) and those affecting protein-coding DNA (right circles). Nonsynonymous SBS leads to amino-acid changes, whereas synonymous mutations do not have an effect on the protein sequence. g Top panels: genomic distribution of the observed versus the expected amount of mutations per genome per doubling at promoter and promoter-flanking regions. Error bars represent the standard deviation. Bottom panels: log2 of the ratio between the total number of observed versus the total number of the expected amount of mutations at promoter and promoter-flanking regions. Asterisks denote statistically significant differences between observed and expected.
Fig. 1 In vitro mutation accumulation in PSCs (n = 5), liver stem cells (n = 4), and intestinal stem cells (n = 6). a Schematic overview of the experimental setup to determine in vitro-accumulated mutations in individual human PSCs, liver stem cells, and intestinal stem cells. Clonal stem cell lines were cultured for ~2–5 months during which mutations were allowed to accumulate. At the end of the culture period, a second clonal step was performed, and the derivative subclones were expanded until enough DNA could be isolated for WGS analysis. A biopsy or bulk culture was used as a reference sample to determine and exclude all germline variants, which were subtracted from the clone (comparison 1) and from the subclone (comparison 2). Finally, with these results, the clonal variants were subtracted to identify all variants that were unique to the subclone. b Growth curves for PSCs (green), liver stem cells (red), and intestinal stem cells (blue). c Box–whisker plots showing the median, first and third quartiles, and minimum and maximum of the number of indels per genome per population doubling (statistical test used: ANOVA). d Box–whisker plots showing the median, first and third quartiles, and minimum and maximum of the number of SBS per genome per population doubling. Statistical test used: ANOVA. e Top panels: genomic distribution of the observed versus the expected amount of mutations per genome per doubling. Bottom panels: log2 of the ratio between the total number of observed mutations versus the total number of the expected amount of mutations. Asterisks denote statistically significant differences between observed and expected (binomial test). CDS coding sequence. f Relative number of SBS per cell type (left circles) and those affecting protein-coding DNA (right circles). Nonsynonymous SBS leads to amino-acid changes, whereas synonymous mutations do not have an effect on the protein sequence. g Top panels: genomic distribution of the observed versus the expected amount of mutations per genome per doubling at promoter and promoter-flanking regions. Error bars represent the standard deviation. Bottom panels: log2 of the ratio between the total number of observed versus the total number of the expected amount of mutations at promoter and promoter-flanking regions. Asterisks denote statistically significant differences between observed and expected.CC BY · PubMed Central
Fig. 2 Mutational spectrum and signature analysis. Data are derived from biological replicates. a Relative contribution of the indicated base substitution types to the mutation spectrum. Per stem cell type, data are represented as the mean relative contribution of each mutation type over all subclones (liver n = 4, PSC n = 5, and SI ASC n = 6). Error bars represent the standard deviation from the mean. The total number of SBS is indicated. b Box–whisker plots showing the median, first and third quartiles, and minimum and maximum of the number of mutations per genome per population doubling under 20% and 3% O2. Statistical test used: two-sided t test. c Relative contribution of the indicated base substitution types to the mutation spectrum of individual human pluripotent stem cell lines (n = 3) cultured for 3 months under 3% oxygen levels. Data are represented as the mean relative contribution of each mutation type over all subclones. Error bars represent the standard deviation from the mean. The total number of SBS is indicated.
Fig. 2 Mutational spectrum and signature analysis. Data are derived from biological replicates. a Relative contribution of the indicated base substitution types to the mutation spectrum. Per stem cell type, data are represented as the mean relative contribution of each mutation type over all subclones (liver n = 4, PSC n = 5, and SI ASC n = 6). Error bars represent the standard deviation from the mean. The total number of SBS is indicated. b Box–whisker plots showing the median, first and third quartiles, and minimum and maximum of the number of mutations per genome per population doubling under 20% and 3% O2. Statistical test used: two-sided t test. c Relative contribution of the indicated base substitution types to the mutation spectrum of individual human pluripotent stem cell lines (n = 3) cultured for 3 months under 3% oxygen levels. Data are represented as the mean relative contribution of each mutation type over all subclones. Error bars represent the standard deviation from the mean. The total number of SBS is indicated.CC BY · PubMed Central
Fig. 3 Mutational signature analysis. a The 96-type mutational profiles of signatures A–C extracted by nonnegative matrix factorization from the mutational landscape of all in vitro samples. b Cosine similarity heatmap between the mutational profiles of the extracted signatures A–C and the samples. Unsupervised hierarchical clustering of the samples based on the relative contribution of the extracted signatures to the mutational profile resulted in a clear segregation of the samples by cell type. c Cosine similarity heatmap between the mutational profiles of the extracted signatures A–C, and the COSMIC Signatures. e Cosine similarity heatmap between the COSMIC Signatures and the mutational profiles of the in vitro stem cell types and the previously described in vivo ASCs24. Liver = liver stem cells in vivo, SI = intestinal stem cells in vivo, colon = colon stem cells in vivo. Unsupervised hierarchical clustering of the samples was performed based on the cosine of the mutational profile to the COSMIC Signatures. d Cosine similarity heatmap between COSMIC Signatures and the mutational profiles of all in vitro stem cell subclones and the previously described in vivo ASCs24. Liver = liver stem cells in vivo, SI = intestinal stem cells in vivo, colon = colon stem cells in vivo. Unsupervised hierarchical clustering of the samples was performed based on the cosine of the mutational profile to the COSMIC Signatures. f Relative contribution of the COSMIC Signatures to the different stem cell types.
Fig. 3 Mutational signature analysis. a The 96-type mutational profiles of signatures A–C extracted by nonnegative matrix factorization from the mutational landscape of all in vitro samples. b Cosine similarity heatmap between the mutational profiles of the extracted signatures A–C and the samples. Unsupervised hierarchical clustering of the samples based on the relative contribution of the extracted signatures to the mutational profile resulted in a clear segregation of the samples by cell type. c Cosine similarity heatmap between the mutational profiles of the extracted signatures A–C, and the COSMIC Signatures. e Cosine similarity heatmap between the COSMIC Signatures and the mutational profiles of the in vitro stem cell types and the previously described in vivo ASCs24. Liver = liver stem cells in vivo, SI = intestinal stem cells in vivo, colon = colon stem cells in vivo. Unsupervised hierarchical clustering of the samples was performed based on the cosine of the mutational profile to the COSMIC Signatures. d Cosine similarity heatmap between COSMIC Signatures and the mutational profiles of all in vitro stem cell subclones and the previously described in vivo ASCs24. Liver = liver stem cells in vivo, SI = intestinal stem cells in vivo, colon = colon stem cells in vivo. Unsupervised hierarchical clustering of the samples was performed based on the cosine of the mutational profile to the COSMIC Signatures. f Relative contribution of the COSMIC Signatures to the different stem cell types.CC BY · PubMed Central
Fig. 4 Modeling the oncogenic mutations in in vitro-cultured stem cells. a The number of oncogenic mutations as a function of the number of in vitro-produced cells. b The probability of oncogenic mutations (x-axis) as a function of the number of in vitro-produced ASCs (primary y-axis,) and as a function of years of adult life (secondary y-axis). c The probability of BRAFV600E mutations (x-axis) as a function of the number of in vitro-produced ASCs (primary y-axis), and as a function of years of adult life (secondary y-axis).
Fig. 4 Modeling the oncogenic mutations in in vitro-cultured stem cells. a The number of oncogenic mutations as a function of the number of in vitro-produced cells. b The probability of oncogenic mutations (x-axis) as a function of the number of in vitro-produced ASCs (primary y-axis,) and as a function of years of adult life (secondary y-axis). c The probability of BRAFV600E mutations (x-axis) as a function of the number of in vitro-produced ASCs (primary y-axis), and as a function of years of adult life (secondary y-axis).CC BY · PubMed Central
Fig. 5 The effect of oxygen tension on the risk of acquiring oncogenic mutations in in vitro-cultured PSCs. a The number of oncogenic mutations as a function of the number of in vitro-produced cells for pluripotent stem cells cultured under 20% and 3% oxygen. b Top panels: genomic distribution of the observed versus the expected amount of mutations per genome per doubling. Bottom panels: log2 of the ratio between the total number of observed mutations versus the total number of the expected amount of mutations. Asterisks denote statistically significant differences between observed and expected (binomial test). CDS coding sequence.
Fig. 5 The effect of oxygen tension on the risk of acquiring oncogenic mutations in in vitro-cultured PSCs. a The number of oncogenic mutations as a function of the number of in vitro-produced cells for pluripotent stem cells cultured under 20% and 3% oxygen. b Top panels: genomic distribution of the observed versus the expected amount of mutations per genome per doubling. Bottom panels: log2 of the ratio between the total number of observed mutations versus the total number of the expected amount of mutations. Asterisks denote statistically significant differences between observed and expected (binomial test). CDS coding sequence.CC BY · PubMed Central
Fig. 6 RNA-seq analysis of human adult and pluripotent stem cells. Heatmap and unsupervised hierarchical clustering of RNA-seq data for all genes for human PSCs, human ES cells, human liver stem cells, and human intestinal stem cells.
Fig. 6 RNA-seq analysis of human adult and pluripotent stem cells. Heatmap and unsupervised hierarchical clustering of RNA-seq data for all genes for human PSCs, human ES cells, human liver stem cells, and human intestinal stem cells.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 1

  1. Barras, D. BRAF mutation in colorectal cancer: an update. Biomark. Cancer 7, 9–12 (2015).

Cited by

See all 124

Metadata

Authors
Kuijk, E., Jager, M., van der Roest, B., Locati, M. D., Van Hoeck, A., Korzelius, J., Janssen, R., Besselink, N., Boymans, S., van Boxtel, R., & Cuppen, E.
Affiliations
  • University Medical Center Utrecht (NL)
  • Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
Corresponding author
  • Kuijk, Ewart
  • Cuppen, Edwin
Venue
Nature Communications
Published
2020-05-19
Volume
11
Issue
1
Pages
2493-2493
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3028024776
Cited by
124
References
55
Citations by year
2026: 9 · 2025: 17 · 2024: 17 · 2023: 25 · 2022: 15 · 2021: 33 · 2020: 5
FWCI
6.30
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Kent Academic Repository (University of Kent) (acceptedVersion)
  • Kent Academic Repository (University of Kent) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Gravitation Program Cancer Genomics.nl)
  • ZonMw (93512003)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
Keywords
in vitro mutagenesis, stem cell culture, human pluripotent stem cells, adult stem cells, intestinal stem cells, liver stem cells, mutational signatures, oxidative stress, oxygen partial pressure, oncogenic mutations, stem cell therapy safety, whole genome sequencing
MeSH terms
Mutation Accumulation, Whole Genome Sequencing, Adult, Algorithms, Cells, Cultured, DNA Mutational Analysis, Humans, Intestines, Liver, Models, Genetic, Mutation, Regenerative Medicine, Adult Stem Cells, Induced Pluripotent Stem Cells, Mutation Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The mutational impact of culturing human pluripotent and adult stem cells. https://app.cochat.ai/papers/10.1038/s41467-020-16323-4
The paper
Kuijk, E., Jager, M., van der Roest, B., Locati, M. D., Van Hoeck, A., Korzelius, J., Janssen, R., Besselink, N., Boymans, S., van Boxtel, R., & Cuppen, E. (2020). The mutational impact of culturing human pluripotent and adult stem cells. Nature Communications. https://doi.org/10.1038/s41467-020-16323-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.